Showing results (1-10 of 246) with videos related to
Sort By:
Pageof 25
Acta Oncologica (Stockholm, Sweden)|January 1, 1992
The prevention of breast cancer through reduced ovarian steroid exposureD V Spicer, M C PikeBreast Cancer Research : BCR|March 16, 2001
Future possibilities in the prevention of breast cancer: luteinizing hormone-releasing hormone agonistsD V Spicer, M C PikeJournal of the National Cancer Institute. Monographs|January 1, 1994
Sex steroids and breast cancer preventionD V Spicer, M C PikeJournal of Cellular Biochemistry. Supplement|January 1, 1993
The chemoprevention of breast cancer by reducing sex steroid exposure: perspectives from epidemiologyM C Pike, D V SpicerEndocrine-Related Cancer|July 21, 2000
Hormonal contraception and chemoprevention of female cancersM C Pike, D V SpicerBreast Cancer Research and Treatment|November 1, 1993
Breast cancer prevention through modulation of endogenous hormonesD V Spicer, M C PikeContraception|September 1, 1991
GnRH agonists as contraceptive agents: predicted significantly reduced risk of breast cancerD V Spicer, D Shoupe, M C PikeCancer Investigation|January 1, 1995
The endocrine prevention of breast cancerD V Spicer, E A Krecker, M C PikeCancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 9, 2001
Reversal of gonadotropin-releasing hormone agonist induced reductions in mammographic densities on stopping treatmentI T Gram, G Ursin, D V Spicer, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 24, 2001
Mammographic density changes during the menstrual cycleG Ursin, Y R Parisky, M C Pike, et al.Pageof 25